Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myung-Ju Ahn

Showing results (1-10 of 633) with videos related to

Pageof 64
Sort By:
Journal of Thoracic Disease|May 1, 2018
Consolidation of immunotherapy becomes new standard of care in unresectable stage III non-small cell lung cancerMyung-Ju Ahn
The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi|February 24, 2004
[Chemotherapy in the treatment of gastric cancer]Myung-Ju Ahn
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 28, 2019
Combination of Osimertinib with Durvalumab in Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer: Is There Room for Reinvestigation?Myung-Ju Ahn
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 21, 2017
Cell-free DNA Analysis in SCLC: Ready for Clinical Practice?Myung-Ju Ahn
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2015
Reply to E. Giovannetti et alMyung-Ju Ahn
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 29, 2020
Molecular Testing in Lung Cancer: Still Big Gap in Implementation for Real-World UseMyung-Ju Ahn
Current Opinion in Oncology|November 13, 2020
Immune checkpoint inhibitors in driver mutation-positive nonsmall cell lung cancer: is there a role?Jiyun Lee, Myung-Ju Ahn
Cancer Treatment Reviews|September 29, 2021
Brain metastases in patients with oncogenic-driven non-small cell lung cancer: Pros and cons for early radiotherapyJiyun Lee, Myung-Ju Ahn
Future Oncology (London, England)|November 21, 2025
Datopotamab deruxtecan versus docetaxel for non-small cell lung cancer: a plain language summary of the TROPION-Lung01 studyJacob Sands, Myung-Ju Ahn
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 26, 2021
A Response to the Letter to the Editor: Osimertinib Leads the Way Towards Improving Outcomes of EGFR-Mutant NSCLC With Leptomeningeal MetastasesJiyun Lee, Myung-Ju Ahn
Pageof 64

Showing results (1-10 of 633) with videos related to

Sort By:
Pageof 64
Journal of Thoracic Disease|May 1, 2018
Consolidation of immunotherapy becomes new standard of care in unresectable stage III non-small cell lung cancerMyung-Ju Ahn
The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi|February 24, 2004
[Chemotherapy in the treatment of gastric cancer]Myung-Ju Ahn
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 28, 2019
Combination of Osimertinib with Durvalumab in Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer: Is There Room for Reinvestigation?Myung-Ju Ahn
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 21, 2017
Cell-free DNA Analysis in SCLC: Ready for Clinical Practice?Myung-Ju Ahn
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2015
Reply to E. Giovannetti et alMyung-Ju Ahn
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 29, 2020
Molecular Testing in Lung Cancer: Still Big Gap in Implementation for Real-World UseMyung-Ju Ahn
Current Opinion in Oncology|November 13, 2020
Immune checkpoint inhibitors in driver mutation-positive nonsmall cell lung cancer: is there a role?Jiyun Lee, Myung-Ju Ahn
Cancer Treatment Reviews|September 29, 2021
Brain metastases in patients with oncogenic-driven non-small cell lung cancer: Pros and cons for early radiotherapyJiyun Lee, Myung-Ju Ahn
Future Oncology (London, England)|November 21, 2025
Datopotamab deruxtecan versus docetaxel for non-small cell lung cancer: a plain language summary of the TROPION-Lung01 studyJacob Sands, Myung-Ju Ahn
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 26, 2021
A Response to the Letter to the Editor: Osimertinib Leads the Way Towards Improving Outcomes of EGFR-Mutant NSCLC With Leptomeningeal MetastasesJiyun Lee, Myung-Ju Ahn
Pageof 64